OMRON VENTURES Joins Theranica's Series B Funding Round as Strategic Investor
Strategic investment signals positive response of healthcare community to Theranica's new approach to migraine management
NETANYA, Israel, May 13, 2019 -- (Healthcare Sales & Marketing Network) -- Theranica today announced OMRON VENTURES has joined its... Devices, Neurology, Venture Capital Theranica Bio-Electronics, Nerivio Migra, neuromodulation, migraine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Brain | Funding | Headache | Israel Health | Marketing | Middle East Health | Migraine | Neurology | Pharmaceuticals | Venture Capital